Kenya’s BAT Kenya resumes Velo nicotine pouches after citing regulatory clarity

Mar.03
Kenya’s BAT Kenya resumes Velo nicotine pouches after citing regulatory clarity
BAT Kenya says it has resumed sales of Velo oral nicotine pouches after receiving regulatory clarity, reinforcing its push into non-combustible products as cigarette consumption falls.The company reported a 10% drop in turnover in 2025, with revenue closing at KSh23.2 billion (about $178.64 million), largely attributed to the growing presence of illegal tobacco products.

Key Takeaways

 

  • BAT Kenya said it resumed Velo nicotine pouch sales after regulatory clarity
  • The company reported 2025 revenue of KSh23.2 billion (about $178.64 million), citing illicit tobacco growth as a key factor
  • Finance Director Philemon Kipkemoi said Velo contributed about KSh232 million (about $1.786 million) from July–December 2025
  • BAT Kenya shifted to an import model after divesting its local plant and currently sources Velo from Pakistan
  • Kipkemoi projected Velo could reach 15%–25% of BAT Kenya revenue in three to five year

 


 

2Firsts, March 3, 2026

 

According to Capital FM, BAT Kenya said it has resumed sales of its Velo oral nicotine pouches after receiving regulatory clarity, marking a renewed push into non-combustible products as cigarette sales decline.

 

The company said Velo’s return underscores its strategy to diversify revenue streams in a market facing increased competition from illicit tobacco products and falling cigarette consumption. 

 

BAT Kenya reported a 10% drop in turnover in 2025, with revenue closing at KSh23.2 billion (about $178.64 million), and attributed the decline largely to the growing presence of illegal tobacco products.

 

Finance Director Philemon Kipkemoi said Velo contributed about 1% of total turnover between July and December 2025, translating to roughly KSh232 million (about $1.786 million). He said the company’s re-entry in the second half of last year was driven by a more suitable regulatory environment that now accommodates oral nicotine products.

 

Following the divestment of its local manufacturing plant, BAT Kenya has shifted to an import model. The company currently sources Velo pouches from Pakistan, but said it may reconsider local production depending on the product’s performance.

 

At the group level, British American Tobacco said it had 34 million non-combustible product consumers by the end of 2025, representing 68% of its target of 50 million users by 2030. The group aims to generate 50% of its revenue from non-combustible products by 2035, up from the current 18%.

 

Kipkemoi projected that Velo could account for between 15% and 25% of total revenue within the next three to five years. The resumption of sales was described as part of BAT Kenya’s broader strategy to expand alternative nicotine products while complying with evolving regulations and responding to changing consumer preferences.

 

Image source: Capital FM.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More
FDA Adds 18 Tobacco Harmful Constituents and Seeks Comment on 3 More
U.S. Food and Drug Administration published a Federal Register notice finalizing the addition of 18 constituents to the established list of Harmful and Potentially Harmful Constituents in tobacco products. With the update, the list now contains 111 constituents. FDA also proposed adding three more constituents to the list and opened a public comment period ending at 11:59 p.m. ET on May 26, 2026.
Apr.24 by 2FIRSTS.ai
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new Argentine framework for tobacco and nicotine marks a shift from prohibition towards registration, traceability, and health surveillance. Juan Facundo Teme told 2Firsts that adult consumers and some of the commercial sector are cautiously optimistic, although concerns remain about flavors, registration costs, and market access.
May.11
ELFBAR Resolves Global Dispute Over "ELF" Trademark with VPR Brands LP
ELFBAR Resolves Global Dispute Over "ELF" Trademark with VPR Brands LP
ELFBAR announces global settlement with VPR Brands LP over "ELF" trademark dispute, covering major markets like US, Canada, UK.
Apr.01 by 2FIRSTS.ai
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
According to a complaint filed on March 17 in the U.S. District Court for the Northern District of Texas, Fontem US, LLC and Texas retailer OM Investment, LLC sued the Food and Drug Administration and the Department of Health and Human Services over FDA’s refusal-to-file decision for certain Zone nicotine pouch PMTAs.
Mar.19 by 2FIRSTS.ai
U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
North Carolina hemp provider JLT Imports Inc. has filed suit in California federal court seeking cancellation of the “Lost Mary” vape trademark held by Chinese company Imiracle (HK) Ltd.
Mar.30 by 2FIRSTS.ai
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
2Firsts|Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window
Sesh said its Premarket Tobacco Product Application (PMTA) for 64 nicotine pouch SKUs has been accepted by the U.S. Food and Drug Administration (FDA) and advanced to the Filing stage, entering substantive scientific review. Industry experts say the development signals that the application has crossed a key technical and regulatory threshold, while also highlighting growing divergence in regulatory capability and market positioning within the nicotine pouch category.
Special Report
Mar.24 by 2FIRSTS.ai